1. Home
  2. NCNO vs VKTX Comparison

NCNO vs VKTX Comparison

Compare NCNO & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NCNO
  • VKTX
  • Stock Information
  • Founded
  • NCNO 2011
  • VKTX 2012
  • Country
  • NCNO United States
  • VKTX United States
  • Employees
  • NCNO N/A
  • VKTX N/A
  • Industry
  • NCNO Computer Software: Prepackaged Software
  • VKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NCNO Technology
  • VKTX Health Care
  • Exchange
  • NCNO Nasdaq
  • VKTX Nasdaq
  • Market Cap
  • NCNO 3.4B
  • VKTX 3.4B
  • IPO Year
  • NCNO 2020
  • VKTX 2015
  • Fundamental
  • Price
  • NCNO $27.47
  • VKTX $24.15
  • Analyst Decision
  • NCNO Buy
  • VKTX Strong Buy
  • Analyst Count
  • NCNO 13
  • VKTX 11
  • Target Price
  • NCNO $41.15
  • VKTX $95.18
  • AVG Volume (30 Days)
  • NCNO 1.3M
  • VKTX 3.8M
  • Earning Date
  • NCNO 05-28-2025
  • VKTX 04-23-2025
  • Dividend Yield
  • NCNO N/A
  • VKTX N/A
  • EPS Growth
  • NCNO N/A
  • VKTX N/A
  • EPS
  • NCNO N/A
  • VKTX N/A
  • Revenue
  • NCNO $522,980,000.00
  • VKTX N/A
  • Revenue This Year
  • NCNO $15.61
  • VKTX N/A
  • Revenue Next Year
  • NCNO $14.03
  • VKTX N/A
  • P/E Ratio
  • NCNO N/A
  • VKTX N/A
  • Revenue Growth
  • NCNO 13.19
  • VKTX N/A
  • 52 Week Low
  • NCNO $27.29
  • VKTX $23.27
  • 52 Week High
  • NCNO $43.20
  • VKTX $82.00
  • Technical
  • Relative Strength Index (RSI)
  • NCNO 34.33
  • VKTX 33.93
  • Support Level
  • NCNO $27.96
  • VKTX $25.80
  • Resistance Level
  • NCNO $30.02
  • VKTX $29.60
  • Average True Range (ATR)
  • NCNO 0.81
  • VKTX 1.61
  • MACD
  • NCNO 0.11
  • VKTX -0.30
  • Stochastic Oscillator
  • NCNO 6.59
  • VKTX 10.72

About NCNO nCino Inc.

Ncino Inc is a provider of cloud-based software for financial institutions. Its software solution digitizes, automates, and streamlines inefficient and complex processes & workflow and utilizes data analytics & artificial intelligence that enables financial institutions to onboard new clients, make loans and manage the entire loan life cycle, open deposits, and other accounts and manage regulatory compliance. It also offers professional services, including configuration & implementation, training, and advisory services. Ncino generates the majority of its revenue from subscription services. The company caters to financial institutions, enterprise banks, regional banks, community banks, and credit unions. The vast majority of its revenue comes from the United States.

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Share on Social Networks: